2021
DOI: 10.1177/20402066211036822
|View full text |Cite
|
Sign up to set email alerts
|

Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs

Abstract: Background Drug repurposing is a cost-effective strategy to identify drugs with novel effects. We searched for drugs exhibiting inhibitory activity to Herpes Simplex virus 1 (HSV-1). Our strategy utilized gene expression data generated from HSV-1-infected cell cultures which was paired with drug effects on gene expression. Gene expression data from HSV-1 infected and uninfected neurons were analyzed using BaseSpace Correlation Engine (Illumina®). Based on the general Signature Reversing Principle (SRP), we hyp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…The following HSV-1 strains were employed in this study: KOS (VR-1493; ATCC), and a previously detailed [ 14 , 15 ] KOS-based recombinant virus in which enhanced green fluorescent protein (EGFP) and monomeric red fluorescent protein (RFP) are reporters whose expression is driven by the viral promoters ICP0 and Glycoprotein C, respectively (HSV-1 DualFP).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The following HSV-1 strains were employed in this study: KOS (VR-1493; ATCC), and a previously detailed [ 14 , 15 ] KOS-based recombinant virus in which enhanced green fluorescent protein (EGFP) and monomeric red fluorescent protein (RFP) are reporters whose expression is driven by the viral promoters ICP0 and Glycoprotein C, respectively (HSV-1 DualFP).…”
Section: Methodsmentioning
confidence: 99%
“…Monolayer cultures of NPCs were derived from hiPSC line SC0000020 (subclone SF) as previously described [ 14 , 15 ]. NPCs were infected as monolayer cultures at a range of low multiplicities of infection (MOI 0.1–0.0001) with HSV-1, strain KOS, in the presence or absence of ACV.…”
Section: Methodsmentioning
confidence: 99%